Company
Clinipace
Caidya is a different kind of CRO by design.
Also known as Clinipace, Inc
- Status
- Acquiredas of 2026-09-23Source (opens in a new tab)
- Business model
- B2B
- Customers
- innovative biopharma companies
- Legal name
- Clinipace, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Clinipace is a clinical research organization whose services are enhanced by a proprietary on-demand software platform and clinical research services. Acquired by dMed in April 2021.
Funding snapshot
- Total raised
- $122MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $4.1M2020-09-21
Funding rounds
- Round, 2020
- $4.1M2020-09-21, SEC form D sold, 10 investors
- Round, 2019
- $14.7M2019-10-10, SEC form D sold, 16 investors
- Round, 2019
- $3.8M2019-07-23, SEC form D sold, 13 investors
- Round, 2019
- $4M2019-03-01, SEC form D sold, 13 investors
- Round, 2018
- $5.7M2018-08-21, SEC form D sold, 13 investors
- Round, 2017
- $10M2017-12-04, SEC form D sold, 16 investors
- Round, 2017
- $3M2017-11-03, SEC form D sold, 13 investors
- Round, 2016
- $3.7M2016-07-08, SEC form D sold, 10 investors
- Round, 2015
- $17.5M2015-01-02, SEC form D sold, 13 investors
- Round, 2014
- $4M2014-09-24, SEC form D sold, 8 investors
- Round, 2014
- $2.6M2014-02-24, SEC form D sold, 1 investor
- Round, 2014
- $3M2014-01-29, SEC form D sold, 1 investor
- Round, 2012
- $9.1M2012-10-12, SEC form D sold, 3 investors
- Round, 2012
- $13.3M2012-09-04, SEC form D sold, 6 investors
- Round, 2011
- $15.6M2011-09-23, SEC form D sold, 14 investors
- More rounds
- 3 earlier rounds recorded
About the company
- Status notes
- Acquired by dMed in April 2021.
Exit
- Acquisition
- 2021-04
Loading relationship preview